Connect with us

Special

Everything you need to know about abdominal separation and how to fix it

The condition is the partial or complete separation of the rectus abdominis muscles during and after pregnancy

Published

on

One in two women suffers from abdominal separation after pregnancy. Left untreated, the condition may persist well into the menopausal years and cause urinary incontinence, back pain, hernia and reduced quality of life.

Many women experience diastasis recti abdominis (DRA) or abdominal separation—a separation of the rectus abdominis muscles in the midline of the stomach—after pregnancy.

The condition may persist well after giving birth—it has been diagnosed in 52 per cent of urogynecological menopausal patients.

Dr Linas Venclauskas, a bariatric surgeon at Nordbariatric clinic in Kaunas, Lithuania, says that every second parous woman has DRA on average.

The most discernible signs are protruding belly, which, in most cases, does not go away even with physical exercise or diets, and a visibly wider linea alba that runs down the midline of the stomach.

Pregnancy causes rectus abdominis muscles to separate to the sides resulting in a lost abdominal wall elasticity,” he explains.

“Abdominis rectus muscles are connected with a tendinous tissue which is visible as a whitish line from the exterior. Severe pressure on the muscles makes the tendinous tissue expand to the sides.”

If untreated, the condition may trigger severe health problems, the surgeon says.

“The incorrect position of the rectus abdominis muscle distributes the load onto other muscle groups—the spine, waist, pelvis.

“This may cause spine problems and lower back pains, hernia, urinary incontinence, constant bloating, and chronic constipation in some cases.”

Some women may be more prone to have abdominal separation, and the risk factors include: a large baby compared to a woman’s body, more than one foetus, weak abdominal muscles, less than a year passed after the last pregnancy, previous C-section, and the pregnant woman is over 35 years old, adds Venclauskas.

However, there are no 100 per cent preventive measures, as both active and inactive women can develop it.

Surgery or conservative treatment?

Full symptomatic relief can be achieved through abdominal wall reconstruction surgery, which restores the integrity of the abdominal wall and allows it to protect the internal organs and provide support to the spine.

The procedure can also be combined with other highly-requested postpartum surgeries like a tummy tuck or a mommy makeover.

Dr Venclauskas recommends SCOLA—subcutaneous onlay laparoscopic approach as it avoids midline incision, which preserves the aesthetic appearance and prevents scars.

The procedure also produces less post-surgical pain, faster recovery, and minimal complications.

Although surgery does not affect further pregnancies, it is advised to do it after the last childbirth because the rectus abdominis muscles may separate with each pregnancy.

However, in some cases, conservative treatment might be enough, Dr Laimonas Siupsinskas, a physiotherapist at the clinic, adds.

“If the DRA is less than two fingers in size during the rectus abdominis muscle contraction, the condition might be treated conservatively with physiotherapy—only if the surgeon allows it.

“The physical therapist can evaluate the function of the rectus abdominis and other muscles with relation to the back muscles that make up for the core stabilization of the trunk.”

The physiotherapist says breastfeeding plays a crucial role in the exacerbation of the condition—the concentration of the hormone relaxin during breastfeeding makes the fascia and muscles even more relaxed and stretched. Therefore, conservative treatment should be prescribed with care.

“The worst women can do is try to self-treat the DRA and do the exercises found on the internet,” Siupsinskas adds.

“Only a specialist can prescribe certain physical exercises after an individual consultation, and the training regime should focus on muscles that are imbalanced, weak, or too tight.”

Special

AHA campaign to raise awareness of heart disease in women

Published

on

Fashion, beauty and lifestyle retailers have joined the American Heart Association to raise awareness of heart disease in women.

The Go Red. Shop with Heart. campaign launched at the New York Stock Exchange on 30 January.

Retailers will ask for donations at checkout in February or donate a percentage of proceeds from selected items.

More than four in 10 women in the US have some form of cardiovascular disease, a term for heart and blood vessel conditions such as heart disease and stroke.

Heart disease and stroke kill more women in the US each year than all forms of cancer combined.

Brands taking part include Away, Commando, Lafayette 148, Michael Kors, Reebok, ShopSimon.com, Summersalt, Torrid and White & Warren.

More than 40 other nationwide retailers are also inviting customers to support the organisation this February through its Life Is Why campaign.

Nancy Brown is chief executive officer of the American Heart Association.

She said: “Nearly 1 in 3 women die from cardiovascular disease each year, yet women are still profoundly under-represented in the clinical research, science and medicine that could save their lives.

“Retailers and consumers are uniquely positioned to turn everyday moments into meaningful change through Go Red. Shop with Heart.”

According to the American Heart Association 2026 Heart Disease and Stroke Statistics Update, heart disease is the leading cause of death in the US and stroke is the number four cause of death.

The organisation projects that at least six in 10 US adults will have cardiovascular disease within the next 30 years and related costs are expected to triple.

However, approximately 80 per cent of cardiovascular disease is preventable through lifestyle changes.

Mindy Grossman is a volunteer board member at the American Heart Association and partner and vice chair of Consello.

Grossman said: “Retail has always been a powerful connector.

“Shop with Heart gives our industry a shared platform to lead with purpose and unite consumers in support of heart health.”

Continue Reading

News

Milken launches women’s health network platform

Published

on

Milken Institute has launched the Women’s Health Network digital platform with Velir x Brooklyn Data to speed collaboration and investment across research, care and technology.

The new website creates a hub for members to share content, connect and coordinate projects, with branding and the first public Drupal build delivered by Velir x Brooklyn Data. A launch video premiered on 4 November 2025 at the inaugural steering committee and member luncheon in Washington DC, then featured at the Milken Institute Future of Health Summit.

Phase two is scheduled for February 2026, adding member log-ins for networking and content exchange. Phase three in April 2026 will add advanced collaboration tools and expanded community features.

“This launch represents the type of mission-driven, cross-sector digital work we are incredibly proud to support,” said Eliza Pare, vice-president of client services at Velir. “The Women’s Health Network is poised to transform collaboration in women’s health, and we’re honoured to help build the digital infrastructure that will make that possible.”

Chaired by former first lady Dr Jill Biden, the Women’s Health Network brings together leaders from industry, startups, investors, health systems, patient groups, academia and philanthropy. More than 100 members have joined, with a steering group that includes organisations such as the American Cancer Society, American Heart Association, Amgen, Deloitte, GE Healthcare, Merck, Microsoft, Northwell Health, Organon and others.

Continue Reading

Entrepreneur

Innovate UK opens Women in Innovation Awards

Published

on

Innovate UK has opened the Women in Innovation Awards for 2025 to 2026, with grants of up to £75,000 for as many as 60 winners.

HealthTech winners in 2024 included a tampon that prevents bacterial infections, an AI audio device for visually impaired people, and an app for gynaecological conditions.

The awards target female founders of late-stage start-ups with a minimum viable product, early user traction or revenue, growing teams and plans to raise significant capital within 12 to 24 months.

Liz Kendall, science secretary, said: “The Women in Innovation Awards are unlocking the UK’s untapped potential within our community of women innovators; if men and women started and scaled businesses at the same rate this could be worth as much as £250 billion for the UK economy.
“This record £4.5 million investment will empower ambitious women founders to scale their businesses, drive economic growth, and inspire the next generation of innovators.”

Applicants must operate in advanced manufacturing, digital and technologies, or life sciences, three of the high growth sectors identified in the UK’s Industrial Strategy. Winners receive up to £75,000 plus training, networking and role-modelling opportunities, with tailored support also offered to highly commended applicants.

The competition opened on 26 November 2025 and closes on 4 February 2026.

Since 2016, Innovate UK has invested more than £11m in 200 women innovators through these awards, with up to 60 more to be funded this year.

Last year’s programme drew criticism after Innovate UK initially said it would fund 50 women, then announced only 25 awards at £75,000 each. Following a campaign led by Emma Jarvis, founder of Dearbump, and the ‘Let’s Fund More Women’ group of more than 400 supporters, Innovate UK reversed the decision and confirmed all 50 awards and £4m, saying it was “a mistake and we prioritised wrongly”.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.